-
June 10, 2013
GlaxoSmithKline announced disappointing data from a global phase III study evaluating the use of Tykerb
-
June 10, 2013
Hyperion Therapeutics, Inc. acquired global rights to Buphenyl tablets and powder from Ucyclyd Pharma Inc., a ...
-
June 10, 2013
Gentium S.p.A. announced that it is seeking a re-examination of the negative opinion issued on defibrotide by the ...
-
June 10, 2013
AstraZeneca entered into an agreement with Hanmi Pharmaceutical to resolve patent issues related to Nexium
-
June 10, 2013
Brazil's state-run energy giant Petrobras has confirmed the startup of its floating production storage and ...
-
June 10, 2013
Shares of Lexmark International Inc. reached a new 52-week high of $32.13 on Jun 7, 2013.
-
June 10, 2013
As we enter the bumpy summer months, large-cap US domestic stocks and health-care names are on Louis Navellier's ...
-
June 10, 2013
Shares of GameStop jumped 6.2% to close at $36.75 on Friday, getting a boost from Microsoft's announcement.
-
June 10, 2013
On Jun 6, we maintained our Neutral recommendation on Lincoln Electric Holdings, Inc.
-
June 08, 2013
It is not unusual for stocks on a tear to overrun their mean price targets, which is a signal of how far analysts on ...
-
June 07, 2013
BioLineRx recently announced that it has enrolled the first patient in a phase II study of BL-8040, for the ...
-
June 07, 2013
The FDA panel recently voted in favor of easing safety restrictions related to Glaxo's Avandia.
-
June 07, 2013
Bayer announced positive top-line results from the phase III MYRROR study on VEGF Trap-Eye.
-
June 04, 2013
Apple's gearing up to launch its own internet radio service, but how much will this really affect its stock?
-
May 31, 2013
Always-volatile OmniVision is moving in a positive direction again.
-
May 31, 2013
Sadly, diabetes is quickly becoming a global epidemic. Within these grim statistics, investors can find ...
-
May 30, 2013
Even with weaker margins, investors have bid the #3 poultry producer to all-time highs.
-
May 29, 2013
Smithfield gets a lucrative bid from a Chinese buyer, but will the deal go through?
-
May 21, 2013
Elan seems to be set on wasting the Tysabri windfall instead of returning it to shareholders
-
May 21, 2013
Websense gets a fair deal, given its ongoing growth problems.
